Literature DB >> 21117389

Microvascular complications: pathophysiology and management.

Karunakaran Vithian1, Steven Hurel.   

Abstract

Mesh：

Year:  2010        PMID： 21117389      PMCID： PMC4952418          DOI： 10.7861/clinmedicine.10-5-505

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  26 in total

Review 1.  Nephropathy in patients with type 2 diabetes mellitus.

Authors:  E Ritz; S R Orth
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

2.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 3.  Statins for improving renal outcomes: a meta-analysis.

Authors:  Sabrina Sandhu; Natasha Wiebe; Linda F Fried; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2006-06-08       Impact factor: 10.121

Review 4.  Mechanisms of diabetic nephropathy: role of hypertension.

Authors:  Sara Giunti; David Barit; Mark E Cooper
Journal:  Hypertension       Date:  2006-09-04       Impact factor: 10.190

Review 5.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

6.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

9.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

Authors:  A C Keech; P Mitchell; P A Summanen; J O'Day; T M E Davis; M S Moffitt; M-R Taskinen; R J Simes; D Tse; E Williamson; A Merrifield; L T Laatikainen; M C d'Emden; D C Crimet; R L O'Connell; P G Colman
Journal:  Lancet       Date:  2007-11-07       Impact factor: 79.321

10.  Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.

Authors:  G L Bakris; L Ruilope; F Locatelli; A Ptaszynska; B Pieske; J de Champlain; M A Weber; I Raz
Journal:  Kidney Int       Date:  2007-08-01       Impact factor: 10.612
View more
  12 in total

1.  Effect of integrated approach of yoga therapy on autonomic functions in patients with type 2 diabetes.

Authors:  H T Vinutha; B R Raghavendra; N K Manjunath
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

Review 2.  Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review.

Authors:  Chandrachur Ghosh; Neeladrisingha Das; Sarama Saha; Tathagata Kundu; Debabrata Sircar; Partha Roy
Journal:  J Diabetes Metab Disord       Date:  2022-01-13

3.  Small-vessel occlusion versus large-artery atherosclerotic strokes in diabetics: Patient characteristics, outcomes, and predictors of stroke mechanism.

Authors:  G Ntaios; H Milionis; K Vemmos; K Makaritsis; J Ferrari; D Strbian; S Curtze; T Tatlisumak; P Michel; V Papavasileiou
Journal:  Eur Stroke J       Date:  2016-05-05

4.  Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes.

Authors:  Shaik Sarfaraz Nawaz; Khalid Siddiqui; Muhammad Mujammami; Obeed Alotaibi; Saud Sulaiman Alanazi; Mohamed Rafiullah
Journal:  Int J Gen Med       Date:  2022-04-27

Review 5.  Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.

Authors:  Nabeel Quryshi; Laura E Norwood Toro; Karima Ait-Aissa; Amanda Kong; Andreas M Beyer
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

6.  Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance.

Authors:  Bahar Saberzadeh-Ardestani; Razieh Karamzadeh; Mohsen Basiri; Ensiyeh Hajizadeh-Saffar; Aisan Farhadi; A M J Shapiro; Yaser Tahamtani; Hossein Baharvand
Journal:  Cell J       Date:  2018-05-15       Impact factor: 2.479

Review 7.  Annexin-A1: Therapeutic Potential in Microvascular Disease.

Authors:  Gareth S D Purvis; Egle Solito; Christoph Thiemermann
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

8.  Does type 1 diabetes mellitus affect Achilles tendon response to a 10 km run? A case control study.

Authors:  Andrea M Y Wong; Sean I Docking; Jill L Cook; James E Gaida
Journal:  BMC Musculoskelet Disord       Date:  2015-11-10       Impact factor: 2.362

9.  Factors associated with glycemic status and ability to adapt to changing demands in people with and without type 2 diabetes mellitus: A cross-sectional study.

Authors:  Bertha Cecilia Salazar-González; Esther C Gallegos-Cabriales; Alicia Rivera-Castillo; Arnulfo González-Cantú; Marco Vinicio Gómez-Meza; Jesús Zacarías Villarreal-Pérez
Journal:  SAGE Open Med       Date:  2018-05-07

10.  Predictors of Poor Plasma Glucose Maintenance in Type II Diabetic People with Ophthalmic Complication: The Case of Dessie Hospitals in Ethiopia.

Authors:  Mohammed Abdu Seid; Baye Dagnew
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-24       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.